Citation Impact 2023
Journal Impact Factor: 6.1
5-year Journal Impact Factor: 7.1
Source Normalized Impact per Paper (SNIP): 1.865
SCImago Journal Rank (SJR): 2.578
Speed 2024
Submission to first editorial decision (median days): 12
Submission to acceptance (median days): 145
Usage 2024
Downloads: 2,971,481
Altmetric mentions: 1,091
Articles
Page 109 of 112
-
Citation: Breast Cancer Research 2000 2(Suppl 1):S.35
-
Clinical trials in breast cancer; do we have the right approaches?
Citation: Breast Cancer Research 2000 2(Suppl 1):S.33 -
Blood assays for earlier detection of cancers
Citation: Breast Cancer Research 2000 2(Suppl 1):S.30 -
Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy
Citation: Breast Cancer Research 2000 2(Suppl 1):S.28 -
G1/S control and its deregulation in cancer
Citation: Breast Cancer Research 2000 2(Suppl 1):S.26 -
Role of the ATM gene in radiation sensitivity, relevance to breast cancer treatment
Citation: Breast Cancer Research 2000 2(Suppl 1):S.24 -
p53 action in apoptosis and senescence
Citation: Breast Cancer Research 2000 2(Suppl 1):S.22 -
p53-mediated apoptosis and genomic instability syndromes
Citation: Breast Cancer Research 2000 2(Suppl 1):S.20 -
Drug discovery in the p53 pathway
Citation: Breast Cancer Research 2000 2(Suppl 1):S.18 -
Characterisation of micrometastatic tumor cells
Citation: Breast Cancer Research 2000 2(Suppl 1):S.16 -
Clinical translation of progress in molecular endocrinology
Citation: Breast Cancer Research 2000 2(Suppl 1):S.12 -
Estrogen receptors α and β in the rodent mammary gland
Citation: Breast Cancer Research 2000 2(Suppl 1):S.11 -
Comparative genomic hybridisation analysis of myoepithelial carcinoma of the breast
Citation: Breast Cancer Research 2000 2(Suppl 1):P8.06 -
Relation of gene expression-based tumor subclasses to clinical phenotypes
Citation: Breast Cancer Research 2000 2(Suppl 1):P8.11 -
Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP
Citation: Breast Cancer Research 2000 2(Suppl 1):P8.04 -
REAL Real-Time!
Citation: Breast Cancer Research 2000 2(Suppl 1):P8.02 -
The role of coactivators in oestrogen action
Citation: Breast Cancer Research 2000 2(Suppl 1):S.08 -
Identification of two novel breast cancer associated genes by the differential display method
Citation: Breast Cancer Research 2000 2(Suppl 1):P8.08 -
Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer
Citation: Breast Cancer Research 2000 2(Suppl 1):P7.05 -
AKT-1 and BCL-2 co-expression in breast cancer patients correlates with better survival
Citation: Breast Cancer Research 2000 2(Suppl 1):P7.02 -
Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line
Citation: Breast Cancer Research 2000 2(Suppl 1):P7.04 -
Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation
Citation: Breast Cancer Research 2000 2(Suppl 1):P6.03 -
Setting up an efficient and reliable screening method for novel c-Jun N-terminal kinase substrates
Citation: Breast Cancer Research 2000 2(Suppl 1):P5.05 -
The pathology of inherited breast tumours
Citation: Breast Cancer Research 2000 2(Suppl 1):S.05 -
p16INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy
Citation: Breast Cancer Research 2000 2(Suppl 1):P5.01 -
Estrogen-dependent c-jun upregulation may control cyclin D1 expression
Citation: Breast Cancer Research 2000 2(Suppl 1):P5.03 -
Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.06 -
Analysis of Fhit expression in stages of breast cancer progression
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.12 -
The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.05 -
BRCA2 interacting proteins
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.02 -
Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.16 -
Analysis of chromosome alterations and the E-cadherin and FHIT genes in lobular breast cancer
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.13 -
Modulation of ATM gene expression in a murine mammary epithelial cell line
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.10 -
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
Citation: Breast Cancer Research 2000 2(Suppl 1):P4.04 -
Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer
Citation: Breast Cancer Research 2000 2(Suppl 1):P3.04 -
HER-2 activation and TP53 inactivation as predictors of survival in breast cancer
Citation: Breast Cancer Research 2000 2(Suppl 1):P3.07 -
Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation
Citation: Breast Cancer Research 2000 2(Suppl 1):P3.03 -
Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells
Citation: Breast Cancer Research 2000 2(Suppl 1):P2.06 -
The involvement of the MAPK signalling pathway in the adaptation of MCF-7 cells to long-term oestrogen deprivation
Citation: Breast Cancer Research 2000 2(Suppl 1):P2.05 -
Hairy and enhancer of split homolog-1 (HES-1) mediates the proliferative effect of Beta-estradiol on breast cancer cell lines
Citation: Breast Cancer Research 2000 2(Suppl 1):P2.03 -
Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations
Citation: Breast Cancer Research 2000 2(Suppl 1):P1.15 -
Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families
Citation: Breast Cancer Research 2000 2(Suppl 1):P1.13 -
The importance of breast cancer research from a patient's view: the voices and visions of advocates
Citation: Breast Cancer Research 2000 2(Suppl 1):S.01 -
Germline TP53mutations in Finnish breast cancer patients
Citation: Breast Cancer Research 2000 2(Suppl 1):P1.09 -
Breast cancer in young women: prevalence of LOH at p53, BRCA1 and BRCA2
Citation: Breast Cancer Research 2000 2(Suppl 1):P1.04 -
Denaturing high-performance liquid chromatography (DHPLC) as a fast tool to screen a control population for the occurrence of unclassified variants (UV) in the BRCA1 gene
Citation: Breast Cancer Research 2000 2(Suppl 1):P1.01 -
X chromosome inactivation pattern in female patients with breast cancer
Citation: Breast Cancer Research 2000 2(Suppl 1):P1.10 -
Mammary-specific targeting of the murine BRCA2 breast cancer susceptibility gene in mice
Citation: Breast Cancer Research 2000 2(Suppl 1):P1.16 -
Microarray foray
Citation: Breast Cancer Research 2000 2:8 -
Breast Cancer Research non-peer-review research depository
Citation: Breast Cancer Research 2000 2:1